Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2016 Nov 10;11(11):CD011627.
doi: 10.1002/14651858.CD011627.pub2.

Interventions for preventing and treating incontinence-associated dermatitis in adults

Dimitri Beeckman  1 , Nele Van Damme, Lisette Schoonhoven, Aurélie Van Lancker, Jan Kottner, Hilde Beele, Mikel Gray, Sue Woodward, Mandy Fader, Karen Van den Bussche, Ann Van Hecke, Dorien De Meyer, Sofie Verhaeghe
Affiliations

Interventions for preventing and treating incontinence-associated dermatitis in adults

Dimitri Beeckman et al. Cochrane Database Syst Rev. .

Update in

Abstract

Background: Incontinence-associated dermatitis (IAD) is one of the most common skin problems in adults who are incontinent for urine, stool, or both. In practice, products and procedures are the same for both prevention and treatment of IAD.

Objectives: The objective of this review was to assess the effectiveness of various products and procedures to preventand treat incontinence-associated dermatitis in adults.

Search methods: We searched the Cochrane Incontinence Group Specialised Trials Register, which contains trials identified from the Cochrane Central Register of Controlled Trials (CENTRAL), MEDLINE, MEDLINE In-Process, MEDLINE Epub Ahead of Print, CINAHL, ClinicalTrials.gov, WHO ICTRP and handsearching of journals and conference proceedings (searched 28 September 2016). Additionally we searched other electronic databases: CENTRAL(2015, Issue 4), MEDLINE (January 1946 to May Week 3 2015), MEDLINE In-Process (inception to 26 May 2015), CINAHL(December 1981 to 28 May 2015), Web of Science (WoS; inception to 28 May 2015) and handsearched conference proceedings (to June 2015) and the reference lists of relevant articles, and contacted authors and experts in the field.

Selection criteria: We selected randomised controlled trials (RCTs) and quasi-RCTs, performed in any healthcare setting, with included participants over 18 years of age, with or without IAD. We included trials comparing the (cost) effectiveness of topical skin care products such as skin cleansers, moisturisers, and skin protectants of different compositions and skin care procedures aiming to prevent and treat IAD.

Data collection and analysis: Two review authors independently screened titles, abstracts and full-texts, extracted data, and assessed the risk of bias of the included trials.

Main results: We included 13 trials with 1295 participants in a qualitative synthesis. Participants were incontinent for urine, stool, or both, and were residents in a nursing home or were hospitalised.Eleven trials had a small sample size and short follow-up periods. .The overall risk of bias in the included studies was high. The data were not suitable for meta-analysis due to heterogeneity in participant population, skin care products, skin care procedures, outcomes, and measurement tools.Nine trials compared different topical skin care products, including a combination of products. Two trials tested a structured skin care procedure. One trial compared topical skin care products alongside frequencies of application. One trial compared frequencies of application of topical skin care products.We found evidence in two trials, being of low and moderate quality, that soap and water performed poorly in the prevention and treatment of IAD (primary outcomes of this review). The first trial indicated that the use of a skin cleanser might be more effective than the use of soap and water (risk ratio (RR) 0.39, 95% confidence interval (CI) 0.17 to 0.87; low quality evidence). The second trial indicated that a structured skin care procedure, being a washcloth with cleansing, moisturising, and protecting properties, might be more effective than soap and water (RR 0.31, 95% CI 0.12 to 0.79; moderate quality evidence). Findings from the other trials, all being of low to very low quality, suggest that applying a leave-on product (moisturiser, skin protectant, or a combination) might be more effective than not applying a leave-on product. No trial reported on the third primary outcome 'number of participants not satisfied with treatment' or on adverse effects.

Authors' conclusions: Little evidence, of very low to moderate quality, exists on the effects of interventions for preventing and treating IAD in adults. Soap and water performed poorly in the prevention and treatment of IAD. Application of leave-on products (moisturisers, skin protectants, or a combination) and avoiding soap seems to be more effective than withholding these products. The performance of leave-on products depends on the combination of ingredients, the overall formulation and the usage (e.g. amount applied). High quality confirmatory trials using standardised, and comparable prevention and treatment regimens in different settings/regions are required. Furthermore, to increase the comparability of trial results, we recommend the development of a core outcome set, including validated measurement tools. The evidence in this review is current up to 28 September 2016.

PubMed Disclaimer

Conflict of interest statement

  1. Dimitri Beeckman: none known.

  2. Nele Van Damme: none known.

  3. Lisette Schoonhoven: none known.

  4. Aurélie Van Lancker: none known.

  5. Jan Kottner: none known.

  6. Hilde Beele: none known.

  7. Mikel Gray: none known.

  8. Sue Woodward: none known.

  9. Mandy Fader: none known.

  10. Karen Van den Bussche: none known.

  11. Ann Van Hecke: none known.

  12. Dorien De Meyer: none known.

  13. Sofie Verhaeghe: none known.

Figures

1
1
PRISMA study flow diagram.
2
2
Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies.
3
3
Risk of bias summary: review authors' judgements about each risk of bias item for each included study.
1.1
1.1. Analysis
Comparison 1 Any topical skin care product versus another topical skin care product, Outcome 1 Number of participants with IAD (residual, i.e. not healed).
1.2
1.2. Analysis
Comparison 1 Any topical skin care product versus another topical skin care product, Outcome 2 Number of participants with IAD (new).
1.3
1.3. Analysis
Comparison 1 Any topical skin care product versus another topical skin care product, Outcome 3 Surface affected by IAD (measurement of size of lesion).
1.4
1.4. Analysis
Comparison 1 Any topical skin care product versus another topical skin care product, Outcome 4 Staff time.
1.5
1.5. Analysis
Comparison 1 Any topical skin care product versus another topical skin care product, Outcome 5 Number of participants with IAD completely healed.
1.6
1.6. Analysis
Comparison 1 Any topical skin care product versus another topical skin care product, Outcome 6 IAD severity.
2.1
2.1. Analysis
Comparison 2 Any skin care procedure (method or frequency of application) versus any unstructured skin care procedure, Outcome 1 Number of participants with IAD (residual, i.e. not healed).
2.2
2.2. Analysis
Comparison 2 Any skin care procedure (method or frequency of application) versus any unstructured skin care procedure, Outcome 2 IAD Severity.
See this image and copyright information in PMC

References

References to studies included in this review

Anthony 1987 {published data only}
    1. Anthony D, Barnes E, Malone‐Lee J, Pluck R. A clinical study of Sudocrem in the management of dermatitis due to the physical stress of incontinence in a geriatric population. Journal of Advanced Nursing 1987;12(5):599‐603. [sr‐incont519] - PubMed
Baatenburg de Jong 2004 {published data only}
    1. Baatenburg de Jong H, Admiraal H. Comparing cost per use of 3M Cavilon No Sting Barrier Film with zinc oxide oil in incontinent patients. Journal of Wound Care 2004;13(9):398‐400. [sr‐incont19444] - PubMed
Beeckman 2011 {published data only}
    1. Beeckman D, Verhaeghe S, Defloor T, Schoonhoven L, Vanderwee K. A 3‐in‐1 perineal care washcloth impregnated with dimethicone 3% versus water and pH neutral soap to prevent and treat incontinence‐associated dermatitis: a randomized, controlled clinical trial. Journal of Wound, Ostomy, and Continence Nursing 2011;38(6):627‐34. [sr‐incont42976] - PubMed
Brunner 2012 {published data only}
    1. Brunner M, Droegemueller C, Rivers S, Deuser WE. Prevention of incontinence‐related skin breakdown for acute and critical care patients: comparison of two products. Urologic Nursing 2012;32(4):214‐9. [sr‐incont45816] - PubMed
Buckley 2014 {published data only}
    1. Buckley B, Dofitas R, Baltazar W, Quiambao P, Razor B. Topical zinc oxide based creams in a structured care regimen for the treatment of incontinence associated dermatitis in hospitalized adults and older children: A randomized, controlled trial (Abstract number 321). Neurourology and Urodynamics 2014;33(6):760‐1. [sr‐incont64413]
    1. Razor B, Buckley B, Quiambao P, Dofitas R, Baltazar W. Incontinence‐associated dermatitis (IAD) study: Blinded assessment and treatment with zinc oxide‐based ointment. World Council of Enterostomal Therapists Journal 2014;34(4):13‐23.
Byers 1995 {published data only}
    1. Byers PH, Ryan PA, Regan MB, Shields A, Carta SG. Effects of incontinence care cleansing regimens on skin integrity. Journal of Wound, Ostomy, and Continence Nursing 1995;22(4):187‐92. [sr‐incont2967] - PubMed
Conley 2014 {published data only}
    1. Conley P, McKinsey D, Ross O, Ramsey A, Feeback J. Does skin care frequency affect the severity of incontinence‐associated dermatitis in critically ill patients?. Nursing 2014;44(12):27‐32. [sr‐incont64906] - PubMed
Cooper 2001 {published data only}
    1. Cooper P, Gray D. Comparison of two skin care regimes for incontinence. British Journal of Nursing 2001;10(6 Suppl):S6‐S10. [sr‐incont14649] - PubMed
Dieter 2006 {published data only}
    1. Dieter L, Drolshagen C, Blum K. Cost‐effective, quality care for the patient with incontinence. Thirty‐eigth Annual Meeting of Wound Ostomy and Continence Nurse Society; 2006 June 24‐28; Minneapolis. Minneapolis (MN): Wound Ostomy and Continence Nurse Society, 2006. [sr‐incont27316]
Kennedy 1996 {published data only}
    1. Kennedy KL, Lutz J. Comparison of the efficacy and cost‐effectiveness of three skin protectants in the management of incontinence dermatitis. 1996 European Conference on Advances in Wound Management; 1996 Oct 4; Amsterdam. Amsterdam, 1996. [sr‐incont67959]
Lewis‐Byers 2002 {published data only}
    1. Lewis‐Byers K, Thayer D. An evaluation of two incontinence skin care protocols in a long‐term care setting. Ostomy Wound Management 2002;48(12):44‐51. [sr‐incont15851] - PubMed
Schoonhoven 2015 {published data only}
    1. Schoonhoven L, Gaal BG, Teerenstra S, Adang E, Vleuten C, Achterberg T. Cost‐consequence analysis of "washing without water" for nursing home residents: a cluster randomized trial. International Journal of Nursing Studies 2015;52(1):112‐20. - PubMed
Wang 2011 {published data only}
    1. Wang Y, Zhu X, Zhou M. Comparative observation of Dermlin and Genetime used for fecal incontinence patients with perianal skin damage. Chinese Nursing Research 2011;25(3C):776‐7. [sr‐incont42528]

References to studies excluded from this review

Al‐Samarrai 2007 {published data only}
    1. Al‐Samarrai NR, Uman GC, Al‐Samarrai T, Alessi CA. Introducing a new incontinence management system for nursing home residents. Journal of the American Medical Directors Association 2007;8(4):253‐61. - PMC - PubMed
Bates‐Jensen 2003 {published data only}
    1. Bates‐Jensen BM, Alessi CA, Al Samarrai NR, Schnelle JF. The effects of an exercise and incontinence intervention on skin health outcomes in nursing home residents. Journal of the American Geriatrics Society 2003;51(3):348‐55. - PubMed
Bauer 2007 {published data only}
    1. Bauer C, Galvin EA, Kurosky A, DiBiase RJ, Miller S. Testing the efficacy of two products for the prevention of perineal dermatitis in immune compromised patients: a randomized clinical trial. Oncology Nursing Forum 2007;34(1):218. [sr‐incont67957]
Bennett 1998 {published data only}
    1. Bennett RG, Baran PJ, DeVone LV, Bacetti H, Kristo B, Tayback M, et al. Low airloss hydrotherapy versus standard care for incontinent hospitalized patients. Journal of the American Geriatrics Society 1998;46(5):569‐76. - PubMed
Bliss 2007 {published data only}
    1. Bliss DZ, Zehrer C, Savik K, Smith G, Hedblom E. An economic evaluation of four skin damage prevention regimens in nursing home residents with incontinence: economics of skin damage prevention. Journal of Wound, Ostomy, and Continence Nursing 2007;34(2):143‐52. - PubMed
Brown 1994 {published data only}
    1. Brown DS. Diapers and underpads, part 1: skin integrity outcomes. Ostomy Wound Management 1994;40(9):20‐8. - PubMed
Dealey 1995 {published data only}
    1. Dealey C. Pressure sores and incontinence: a study evaluating the use of topical agents in skin care. Journal of Wound Care 1995;4(3):103‐5. - PubMed
Denat 2011 {published data only}
    1. Denat Y, Khorshid L. The effect of 2 different care products on incontinence‐associated dermatitis in patients with fecal incontinence. Journal of Wound, Ostomy, and Continence Nursing 2011;38(2):171‐6. - PubMed
Fader 2003 {published data only}
    1. Fader M, Clarke‐O'Neill S, Cook D, Dean G, Brooks R, Cottenden A, et al. Management of night‐time urinary incontinence in residential settings for older people: an investigation into the effects of different pad changing regimes on skin health. Journal of Clinical Nursing 2003;12(3):374‐86. - PubMed
Harries 2016 {published data only}
    1. Harries FJ, Begg PA. Non‐rinse skin cleansers: the way forward in preventing incontinence related moisture lesions?. Journal of Wound Care 2016;25(5):268‐76. - PubMed
Holroyd 2014 {published data only}
    1. Holroyd S, Graham K. Prevention and management of incontinence‐associated dermatitis using a barrier cream. British Journal of Community Nursing. Suppl Wound Care 2014;Suppl 12:S32‐8. - PubMed
Iraji 2003 {published data only}
    1. Iraji F, Rezazadeh M. The efficacy of topical sucralfate in comparison with hydrocortizone cream in the treatment of diaper dermatitis: a randomized, double blind clinical trial. Iranian Journal of Dermatology 2003;3(6):8‐12.
James 1975 {published data only}
    1. James WS. A new use for an old ointment: Lantiseptic ointment as a treatment for diaper dermatitis. Journal of the Medical Association of Georgia 1975;64(5):132‐3. - PubMed
Kyung 2014 {published data only}
    1. Kyung HP, Keum SK. Effect of a structured skin care regimen on patients with fecal incontinence. Journal of Wound, Ostomy, and Continence Nursing 2014;41(2):161‐7. - PubMed
Leiby 1994 {published data only}
    1. Leiby DM, Shanahan N. Clinical study: assessing the performance and skin environments of two reusable underpads. Ostomy Wound Management 1994;40(8):30‐7. - PubMed
Lyder 1992 {published data only}
    1. Lyder CH, Clemes‐Lowrance C, Davis A, Sullivan L, Zucker A. Structured skin care regimen to prevent perineal dermatitis in the elderly. Journal of ET Nursing 1992;19(1):12‐6. - PubMed
NCT02475512 2015 {published data only}
    1. NCT02475512, Beeckman D. A total body wash wipe combined with a genital wipe versus standard care (water and pH neutral soap) for washing of incontinent residents in a long‐term care setting: a multicenter prospective randomised controlled clinical trial and health economical analysis in nursing homes. https://clinicaltrials.gov/show/NCT02475512 2015.
Netta‐Turner 2008 {published data only}
    1. Netta‐Turner D, Bucher L, Dixon L, Layton NJ. Riding the research roller coaster: what went right, what went wrong?. Journal of Wound, Ostomy, and Continence Nursing 2008;35(5):469‐75. - PubMed
Pinedo 2012 {published data only}
    1. Pinedo G, Zarate AJ, Inostroza G, Meneses X, Falloux E, Molina O, et al. New treatment for faecal incontinence using zinc‐aluminium ointment: a double‐blind randomized trial. Colorectal Disease 2012;14(5):596‐8. - PubMed
Pittman 2012 {published data only}
    1. Pittman J, Beeson T, Terry C, Kessler W, Kirk L. Methods of bowel management in critical care: a randomized controlled trial. Journal of Wound, Ostomy, and Continence Nursing 2012;39(6):633‐9. - PubMed
Shin 2012 {published data only}
    1. Shin YS, Kim HJ, Moon NK, Ahn YH, Kim KO. The effects of uncoated paper on skin moisture and transepidermal water loss in bedridden patients. Journal of Clinical Nursing 2012;21(17‐18):2469‐76. - PubMed
Su 2015 {published data only}
    1. Su MY, Lin SQ, Zhou YW, Liu SY, Lin A, Lin XR. A prospective, randomized, controlled study of a suspension positioning system used with elderly bedridden patients with neurogenic fecal incontinence. Ostomy Wound Management 2015;61(1):30‐9. - PubMed
Sugama 2012 {published data only}
    1. Sugama J, Sanada H, Shigeta Y, Nakagami G, Konya C. Efficacy of an improved absorbent pad on incontinence‐associated dermatitis in older women: cluster randomized controlled trial. BMC Geriatrics 2012;12:22. - PMC - PubMed
Zehrer 2004 {published data only}
    1. Zehrer CL, Lutz JB, Hedblom EC, Ding L. A comparison of cost and efficacy of three incontinence skin barrier products. Ostomy Wound Management 2004;50(12):51‐8. - PubMed

References to studies awaiting assessment

Kajii 2005 {published data only}
    1. Kajii F, Uchida E, Kamei T, Tanaka J, Kushiro W. Development of a preventive skin care protocol using a skin protection cleaning foam for frail elderly who had urinary and fecal incontinence. Bulletin of St. Luke's College of Nursing 2005;31:26‐35.

References to ongoing studies

NCT02570139 2015 {published data only}
    1. NCT02570139. Multi‐center, randomized trial comparing the efficacy of 3M™ Cavilon™ Advanced Barrier Film for the treatment of incontinence‐associated dermatitis to a commercially available moisture barrier. https://clinicaltrials.gov/show/NCT02570139 (accessed 29 September 2016) 2015.
NCT02690753 2016 {published data only}
    1. NCT02690753. A turn and positioning system and standardized incontinence care combined with tailored repositioning versus a standard repositioning protocol for pressure ulcer prevention: a multicenter prospective randomized controlled clinical trial and health economical analysis in a hospital setting. https://clinicaltrials.gov/show/NCT02690753 (accessed 29 September 2016) 2016.

Additional references

Ananthapadmanabhan 2004
    1. Ananthapadmanabhan K, Moore D, Subramanyan K, Misra M, Meyer F. Cleansing without compromise: the impact of cleansers on the skin barrier and the technology of mild cleansing. Dermatology and Therapy 2004;17:16‐25. - PubMed
Beeckman 2007
    1. Beeckman D, Schoonhoven L, Fletcher J, Furtado K, Gunningberg L, Heyman H, et al. EPUAP classification system for pressure ulcers: European Reliability Study. Journal of Advanced Nursing 2007;60(5):682‐91. - PubMed
Beeckman 2009
    1. Beeckman D, Schoonhoven L, Verhaeghe S, Heyneman A, Defloor T. Prevention and treatment of incontinence‐associated dermatitis: Literature review. Journal of Advanced Nursing 2009;65(6):1141‐54. - PubMed
Beeckman 2010
    1. Beeckman D, Schoonhoven L, Fletcher J, Furtado K, Heyman H, Paquay L. Pressure ulcers and incontinence‐associated dermatitis: Effectiveness of the pressure ulcer classification education tool on classification by nurses. Quality and Safety in Health Care 2010;19(5):e3. - PubMed
Beeckman 2014
    1. Beeckman D, Lancker A, Hecke A, Verhaeghe S. A systematic review and meta‐analysis of incontinence‐associated dermatitis, incontinence, and moisture as risk factors for pressure ulcer development. Nursing in Research & Health 2014;37(3):204‐18. - PubMed
Beeckman 2015a
    1. Beeckman D, Kottner J, IAD International Research Group. Developing a core outcome set for incontinence‐associated dermatitis (IAD) research. www.comet‐initiative.org/studies/details/383 (accessed 8 February 2016).
Bliss 2011
    1. Bliss D, Savik K, Thorson M, Ehman S, Lebak K, Beilman G. Incontinence‐associated dermatitis in critically ill adults: time to development, severity, and risk factors. Journal of Wound, Ostomy, and Continence Nursing 2011;38(4):433‐45. - PubMed
CONSORT 2010
    1. Schulz KF, Altman DG, Moher D, the CONSORT Group. CONSORT 2010 Statement: updated guidelines for reporting parallel group randomised trials. www.consort‐statement.org/consort‐2010 (accessed 8 February 2016).
Corcoran 2013
    1. Corcoran E, Woodward S. Incontinence‐associated dermatitis in the elderly: treatment options. British Journal of Nursing 2013;22(8):450‐7. - PubMed
Du Moulin 2008
    1. Du Moulin MF, Hamers JP, Ambergen AW, Janssen MA, Halfens RJ. Prevalence of urinary incontinence among community‐dwelling adults receiving home care. Research in Nursing & Health 2008;31(6):604‐12. - PubMed
GRADEpro GDT 2014 [Computer program]
    1. GRADE Working Group, McMaster University. GRADEpro GDT. Hamilton (ON): GRADE Working Group, McMaster University, (Accessed 13 April 2016).
Gray 2002
    1. Gray M, Ratliff C, Donovan A. Perineal skin care for the incontinent patient. Advances in Skin & Wound Care 2002;15(4):170‐8. - PubMed
Gray 2007
    1. Gray M, Bliss DZ, Doughty DB, Ermer‐Seltun J, Kennedy‐Evans KL, Palmer MH. Incontinence‐associated dermatitis: a consensus. Journal of Wound, Ostomy, and Continence Nursing 2007;34(1):45‐54. - PubMed
Gray 2010
    1. Gray M. Optimal management of Incontinence‐associated dermatitis in the elderly. American Journal of Clinical Dermatology 2010;11(3):201‐10. - PubMed
Gray 2012
    1. Gray M, Beeckman D, Bliss DZ, Fader M, Logan S, Junkin J, et al. Incontinence‐associated dermatitis: a comprehensive review and update. Journal of Wound, Ostomy, and Continence Nursing 2012;39(1):61‐74. - PubMed
Guyatt 2011
    1. Guyatt GH, Oxman AD, Kunz R, Atkins D, Brozek J, Vist G, et al. GRADE guidelines: 2. Framing the question and deciding on important outcomes. Journal of Clinical Epidemiology 2011;64(4):395‐400. - PubMed
Higgins 2011
    1. Higgins JP, Green S, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from handbook.cochrane.org.
ISC 2009
    1. International Scientific Committee. Recommendations of the International Scientific Committee. Incontinence: evaluation and treatment of urinary incontinence, pelvic organ prolapse and faecal incontinence. Fourth International Consultation on Incontinence; 2008 July 5‐9; Paris. Plymouth, UK: Health Publication Ltd, 2009.
Junkin 2007
    1. Junkin J, Selekof J. Prevalence of incontinence and associated skin Injury in the acute care Inpatient. Journal of Wound, Ostomy, and Continence Nursing 2007;34(3):260‐9. - PubMed
Kottner 2014
    1. Kottner J, Blume‐Peytavi U, Lohrmann C, Halfens R. Associations between individual characteristics and incontinence‐associated dermatitis: a secondary data analysis of a multicentre prevalence study. International Journal of Nursing Studies 2014 Feb 23 [epub ahead of print]. [DOI: 10.1016/j.ijnurstu.2014.02.012] - DOI - PubMed
Kottner 2015
    1. Kottner J, Beeckman D. Incontinence‐associated dermatitis and pressure ulcers in geriatric patients. Giornale Italiano di Dermatologia e Venereologia 2015;150(6):717‐29. - PubMed
Langemo 2011
    1. Langemo D, Hanson D, Hunter S, Thompson P, Oh IE. Incontinence and incontinence‐associated dermatitis. Advances in Skin & Wound Care 2011;24(3):124‐40. - PubMed
Macmillan 2004
    1. Macmillan AK, Merrie AE, Marshall RJ, Parry BR. The prevalence of fecal incontinence in community‐dwelling adults: a systematic review of the literature. Diseases of the Colon and Rectum 2004;47(8):1341‐9. - PubMed
Newman 2007
    1. Newman D, Preston A, Salazar S. Moisture control, urinary and faecal incontinence, and perineal skin management. In: Krasner D, Rodeheaver G, Sibbald R editor(s). Chronic Wound Care: A Clinical Source Book for Healthcare Professionals. 4th Edition. Malvern: HMP Communications, 2007.
NPUAP 2014
    1. National Pressure Ulcer Advisory Panel, European Pressure Ulcer Advisory Panel, Pan Pacific Pressure Injury Alliance. Prevention and Treatment of Pressure Ulcers: Quick Reference Guide. 2nd Edition. Perth: Cambridge Media, 2014. [Available at NPUAP‐EPUAP‐PPPIA Pressure Ulcer Treatment & Prevention, 2014 Quick Reference Guide]
Reference Manager 2012 [Computer program]
    1. Thomson Reuters. Reference Manager Professional Edition Version 12. New York: Thomson Reuters, 2012.
RevMan 2014 [Computer program]
    1. Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager 5 (RevMan 5). Version 5.3. Copenhagen: Nordic Cochrane Centre, The Cochrane Collaboration, 2014.
Shamliyan 2007
    1. Shamliyan T, Wyman J, Bliss DZ, Kane RL, Wilt TJ. Prevention of urinary and fecal Incontinence in adults. Evidence Report/Technology Assessment 2007;161:1‐379. - PMC - PubMed
Sibbald 2003
    1. Sibbald R, Campbell K, Coutts P, Queen D. Intact Skin ‐ an integrity not to be lost. Ostomy/Wound Management 2003;49(6):27‐33. - PubMed

References to other published versions of this review

Beeckman 2015b
    1. Beeckman D, Damme N, Schoonhoven L, Lancker A, Kottner J, Beele H, et al. Interventions for preventing and treating incontinence‐associated dermatitis in adults. Cochrane Database of Systematic Reviews 2015, Issue 4. [DOI: 10.1002/14651858.CD011627] - DOI - PMC - PubMed
Beeckman 2016
    1. Beeckman D, Damme N, Schoonhoven L, Lancker A, Kottner J, Beele H, et al. Interventions for preventing and treating incontinence‐associated dermatitis in adults. Cochrane Database of Systematic Reviews 2016, Issue 11. [DOI: 10.1002/14651858.CD011627.pub2] - DOI - PMC - PubMed

Publication types

MeSH terms